ARTICLE | Deals
Asia’s innovation moment expands beyond China
An analysis of dealmaking in 2024-25 shows Asia biotechs, ex-China, leaning into enabling technologies and first-in-class bets
March 18, 2026 10:32 PM UTC
As China establishes its biotech footprint on the global stage, other regions in Asia are growing their presence, with investments, increasing sophistication and a rising crop of talent — both home-grown and with experience from global MNCs.
Their challenge is to learn from the China model, while finding ways to differentiate and become a valuable destination for investors and partners. ...